The risks and benefits of myopia control – Q&A with Professor Mark Bullimore

We asked renowned myopia scientist and educator Professor Mark Bullimore about his paper on this topic, which clearly outlines that the benefits outweigh the risks with myopia control. Learn about why this analysis was explored, an overview of the paper and the take-home message for clinical practice, especially for childhood contact lens wear.

Learning more about Essilor Stellest

There’s a lot we already know about Essilor Stellest spectacle lenses for correcting and controlling myopia. This article explores recent published studies on visual fields, a crossover trial and the 3-year and 4-year clinical trial data.

What’s in the atropine bottle? Q&A With Professor Mark Bullimore

We asked some key atropine questions of myopia thought leader Professor Mark Bullimore, who has published numerous landmark papers in the field, including his newest on the inconsistencies found in compounded atropine. Learn about the present and the future of atropine treatment for childhood myopia.

The CHAMP Study – Q&A With Professor Karla Zadnik

We had the privilege of chatting with Professor Karla Zadnik who is Principal Investigator of the CHAMP study on low-concentration atropine. Learn about how this study is a unique and important addition to our understanding of topical atropine in myopia control.

Back to basics on axial length measurement

How do A-scan and optical biometry compare? How many measurements should you take and how frequently? Learn about instruments, measurement processes and how to use data on axial length in myopia management.

Understanding the HOYA MiYOSMART spectacle lens performance

The HOYA MiYOSMART was the first of the new generation of myopia control spectacle lenses, with evidence for slowing myopia progression by at least half. Learn more about efficacy, the lens design, visual outcomes and more.

Five things we know about MiSight 1 day

The MiSight 1 day clinical trial is the longest-running soft contact lens study among children, and is now reporting seven-year data. With questions explored including efficacy, cross over from control group to treatment and discontinuation, here’s some of what we’ve learnt along the way.

Driving change in myopia management – Q&A with Elizabeth Lumb

In this Q&A Interview, Optometrist Elizabeth Lumb reflects on the evolution of myopia management in the past five years through two ‘lenses’: as CooperVision’s Director of Global Professional Affairs, Myopia Management, and through the very personal experience of her now 12-year-old niece, Maddy.

What topography data do I need to fit orthokeratology lenses?

Orthokeratology fitting to children is increasing in frequency worldwide, due to its volume of evidence for myopia control. Learn what data inputs are needed and how to best use your topographer for accurate ortho-k lens design.